Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Wagner Heidi L. Insider active across 3 companies, notably ALEXION PHARMACEUTICALS INC. In total, 16 disclosures have been recorded. Split: 0 buy · 11 sells. Total volume traded: €36k. Activity tracked since 12 August 2024. The latest transaction was disclosed on 11 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Wagner Heidi L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
7,000 shares@ US$5.9749.8% of flowCommon StockSEC:0001193125-26-349963:0
7,000 shares@ US$6.0150.2% of flowCommon StockSEC:0001193125-26-349963:1
7,000 shares@ US$5.97100.0% of flowOrdinary SharesSEC:0001193125-25-314741:0
12,700 shares0Ordinary SharesSEC:0000950170-25-108288:0
32,230 shares0Ordinary SharesSEC:0000950170-24-097284:0
166 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:0
3 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:1
6,129 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:2
200 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:3
100 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:4
220 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:5
200 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:6
277 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:7
250 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:8
28 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:9
664 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000244:10
About Wagner Heidi L
Wagner Heidi L is a declarant associated with ALEXION PHARMACEUTICALS INC, where the listed role is SVP, Global Government Affairs, and with Wave Life Sciences Ltd., where the listed role is Director. There are 14 filings in total, and the sampled recent filings run from 2016-02-08 to 2025-12-10, with the transaction nature shown as Cession.